Cyclophosphamide Impurity 21 - Request Quote
Cyclophosphamide Impurity 21
| SZ CAT No: | SZ-C072046 |
| CAS No | NA |
| Mol.F. | C9H21Cl2N2O3P |
| Mol.Wt. | 307.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cyclophosphamide Impurity 21 is chemically 3-Aminopropyl ethyl bis(2-chloroethyl)phosphoramidate. Cyclophosphamide Impurity 21 is supplied with detailed characterization data compliant with regulatory guideline. Cyclophosphamide Impurity 21 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cyclophosphamide.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Cyclophosphamide Impurity 21
Purchase Cyclophosphamide Impurity 21
Cyclophosphamide Impurity 21 suppliers
Cyclophosphamide Impurity 21 manufacturers
Cyclophosphamide Impurity 21 price
Order Cyclophosphamide Impurity 21
Enquire Cyclophosphamide Impurity 21
Cyclophosphamide Impurity 21 cost
Cyclophosphamide Impurity 21 Supplier
Cyclophosphamide Impurity 21 Distributor
Cyclophosphamide Impurity 21 for Method Validation
Cyclophosphamide Reference Standard
Cyclophosphamide Impurity 21 for ANDA Filing
Cyclophosphamide Impurity 21 for Forced Degradation Studies
Cyclophosphamide Impurity 21 Identification Standards
Cyclophosphamide Impurity 21 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


